Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04775745
Title Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Newave Pharmaceutical Inc
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.